Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study
Maya H. Buch, Deepak L. Bhatt, Christina Charles-Schoeman, Jon T. Giles, Ted Mikuls, Gary G. Koch, Steven Ytterberg, Edward Nagy, Hyejin Jo, Kenneth Kwok, Carol A. Connell, Karim Richard Masri, Arne Yndestad
Research output: Contribution to journal › Article › peer-review
5Scopus
citations
Fingerprint
Dive into the research topics of 'Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study'. Together they form a unique fingerprint.